The BioEscalator publishes its Portfolio 2025 – a guide for potential partners & investors

The BioEscalator, the University of Oxford’s biomedical incubator, is very proud to be home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges. Our new Portfolio 2025 brings them together to showcase their innovative approaches and provide a valuable guide for potential investors and partners.

The Portfolio 2025 includes:

• A foreword from Tim Funnell, Partner at Monograph Capital
• One-page profiles of our tenants, from founders and funding to achievements and ambitions
• A map of their partners and investors across the world
• Our alumni
• BioEscalator achievement metrics

We hope you find this Portfolio 2025 an enjoyable guide to the activities of BioEscalator tenants – you can make contact with them via the details given in their profiles, or via us, if you would like to know more.